全文获取类型
收费全文 | 16435篇 |
免费 | 3167篇 |
国内免费 | 134篇 |
专业分类
耳鼻咽喉 | 446篇 |
儿科学 | 461篇 |
妇产科学 | 375篇 |
基础医学 | 1376篇 |
口腔科学 | 294篇 |
临床医学 | 3726篇 |
内科学 | 3078篇 |
皮肤病学 | 370篇 |
神经病学 | 1321篇 |
特种医学 | 614篇 |
外科学 | 2280篇 |
综合类 | 539篇 |
现状与发展 | 2篇 |
一般理论 | 4篇 |
预防医学 | 2496篇 |
眼科学 | 221篇 |
药学 | 655篇 |
1篇 | |
中国医学 | 122篇 |
肿瘤学 | 1355篇 |
出版年
2024年 | 101篇 |
2023年 | 469篇 |
2022年 | 157篇 |
2021年 | 382篇 |
2020年 | 572篇 |
2019年 | 275篇 |
2018年 | 716篇 |
2017年 | 679篇 |
2016年 | 757篇 |
2015年 | 837篇 |
2014年 | 864篇 |
2013年 | 1284篇 |
2012年 | 721篇 |
2011年 | 706篇 |
2010年 | 702篇 |
2009年 | 811篇 |
2008年 | 565篇 |
2007年 | 586篇 |
2006年 | 627篇 |
2005年 | 475篇 |
2004年 | 423篇 |
2003年 | 364篇 |
2002年 | 358篇 |
2001年 | 429篇 |
2000年 | 364篇 |
1999年 | 320篇 |
1998年 | 351篇 |
1997年 | 344篇 |
1996年 | 375篇 |
1995年 | 299篇 |
1994年 | 236篇 |
1993年 | 186篇 |
1992年 | 233篇 |
1991年 | 234篇 |
1990年 | 218篇 |
1989年 | 247篇 |
1988年 | 217篇 |
1987年 | 247篇 |
1986年 | 189篇 |
1985年 | 192篇 |
1984年 | 166篇 |
1983年 | 145篇 |
1982年 | 82篇 |
1981年 | 101篇 |
1980年 | 76篇 |
1979年 | 84篇 |
1978年 | 83篇 |
1976年 | 75篇 |
1974年 | 76篇 |
1973年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Javed Butler Mei Yang Massimiliano Alfonzo Manzi Gregory P. Hess Mahesh J. Patel Thomas Rhodes Michael M. Givertz 《Journal of the American College of Cardiology》2019,73(8):935-944
Background
Epidemiology of patients with worsening heart failure and reduced ejection fraction (HFrEF) in the real-world setting is not well described.Objectives
The purpose of this study was to describe incidence, clinical characteristics, treatment, and outcomes of patients with HFrEF who develop worsening heart failure (HF) in the real-world setting.Methods
Data on patients with incident HFrEF from the National Cardiovascular Data Registry PINNACLE were linked to pharmacy, private practitioner, and hospital claims databases. Incidence, clinical characteristics, treatment (angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist) and outcomes of patients with worsening HF, defined as ≥90 days of stable HF with subsequent worsening requiring intravenous diuretic agents, were assessed.Results
Of 11,064 HFrEF patients, 1,851 (17%) developed worsening HF on average 1.5 years following initial HF diagnosis. Patients who developed worsening HF were more likely to be African American, be octogenarians, and have higher comorbidity burden (p < 0.001). At the onset of worsening HF, 42.4% of patients were on monotherapy, 43.4% were on dual therapy, and 14.1% were on triple therapy. A total of 48%, 61%, and 98% of patients were on >50% target dose for angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, beta-blocker, and mineralocorticoid receptor antagonist, respectively. The 2-year mortality rate was 22.5%, and 56% of patients were rehospitalized within 30 days of the worsening HF event.Conclusions
In the real-world setting, 1 in 6 patients with HFrEF develop worsening HF within 18 months of HF diagnosis. These patients have a high risk for 2-year mortality and recurrent HF hospitalizations. The use of standard-of-care therapies both before and after the onset of worsening HF is low. With high unmet medical need, patients with worsening HF require novel treatment strategies as well as greater optimization of existing guideline-directed therapy. 相似文献2.
3.
4.
5.
6.
7.
“This illness diminishes me. What it does is like theft”: A qualitative meta‐synthesis of people's experiences of living with asthma 下载免费PDF全文
8.
9.
An examination of the clinical outcomes of adolescents and young adults with broad autism spectrum traits and autism spectrum disorder and anorexia nervosa: A multi centre study 下载免费PDF全文
Bruno Palazzo Nazar MD MSc PhD Vanessa Peynenburg BA Charlotte Rhind BSc MSc PhD Rebecca Hibbs PhD Ulrike Schmidt MD PhD Simon Gowers MD PhD Pamela Macdonald PhD Elizabeth Goddard PhD Gillian Todd RMN MSc Nadia Micali MD PhD Janet Treasure OBE PhD FRCP FAED 《The International journal of eating disorders》2018,51(2):174-179
10.